Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons
about
HSV-2: in pursuit of a vaccineSelective retention of herpes simplex virus-specific T cells in latently infected human trigeminal gangliaBovine Herpes Virus 1 (BHV-1) and Herpes Simplex Virus Type 1 (HSV-1) Promote Survival of Latently Infected Sensory Neurons, in Part by Inhibiting ApoptosisT cell memory in the context of persistent herpes viral infectionsThe molecular basis of herpes simplex virus latencyIlluminating viral infections in the nervous systemDistinct APC subtypes drive spatially segregated CD4+ and CD8+ T-cell effector activity during skin infection with HSV-1Human herpes viruses latent infection in the nervous systemCD4 T-cell responses to herpes simplex virus type 2 major capsid protein VP5: comparison with responses to tegument and envelope glycoproteins.Characterization of the IFN-gamma T-cell responses to immediate early antigens in humans with genital herpesInduction of blood brain barrier tight junction protein alterations by CD8 T cells.Role for gamma interferon in control of herpes simplex virus type 1 reactivation.An important role for major histocompatibility complex class I-restricted T cells, and a limited role for gamma interferon, in protection of mice against lethal herpes simplex virus infection.Towards an understanding of the herpes simplex virus type 1 latency-reactivation cycleMucosal immunity to herpes simplex virus type 2 infection in the mouse vagina is impaired by in vivo depletion of T lymphocytes.Pseudorabies virus-induced leukocyte trafficking into the rat central nervous systemImmunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity.Replication of herpes simplex virus type 1 within trigeminal ganglia is required for high frequency but not high viral genome copy number latency.Granzyme A, a noncytolytic component of CD8(+) cell granules, restricts the spread of herpes simplex virus in the peripheral nervous systems of experimentally infected mice.Cell surface expression of H2 antigens on primary sensory neurons in response to acute but not latent herpes simplex virus infection in vivoBovine herpesvirus 1 can infect CD4(+) T lymphocytes and induce programmed cell death during acute infection of cattle.Localization of a passively transferred human recombinant monoclonal antibody to herpes simplex virus glycoprotein D to infected nerve fibers and sensory neurons in vivo.Protective T-cell-based immunity induced in neonatal mice by a single replicative cycle of herpes simplex virusRole of CD28/CD80-86 and CD40/CD154 costimulatory interactions in host defense to primary herpes simplex virus infection.Protective mucosal immunity to ocular herpes simplex virus type 1 infection in mice by using Escherichia coli heat-labile enterotoxin B subunit as an adjuvant.Herpes simplex virus type 1 latency-associated transcript expression protects trigeminal ganglion neurons from apoptosis.A historical analysis of herpes simplex virus promoter activation in vivo reveals distinct populations of latently infected neuronesRecent progress in herpes simplex virus immunobiology and vaccine researchLatent infection with herpes simplex virus is associated with ongoing CD8+ T-cell stimulation by parenchymal cells within sensory gangliaInduction of CD8 T-cell-specific systemic and mucosal immunity against herpes simplex virus with CpG-peptide complexes.The antiviral efficacy of the murine alpha-1 interferon transgene against ocular herpes simplex virus type 1 requires the presence of CD4(+), alpha/beta T-cell receptor-positive T lymphocytes with the capacity to produce gamma interferonPan-HSV-2 IgG antibody in vaccinated mice and guinea pigs correlates with protection against herpes simplex virus 2.Beta interferon and gamma interferon synergize to block viral DNA and virion synthesis in herpes simplex virus-infected cells.Alpha/Beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1.In vivo ablation of CD11c-positive dendritic cells increases susceptibility to herpes simplex virus type 1 infection and diminishes NK and T-cell responses.Diversity of the CD8+ T-cell response to herpes simplex virus type 2 proteins among persons with genital herpes.Expression of cutaneous lymphocyte-associated antigen by CD8(+) T cells specific for a skin-tropic virus.Rapid clearance of herpes simplex virus type 2 by CD8+ T cells requires high level expression of effector T cell functionsTopical herpes simplex virus 2 (HSV-2) vaccination with human papillomavirus vectors expressing gB/gD ectodomains induces genital-tissue-resident memory CD8+ T cells and reduces genital disease and viral shedding after HSV-2 challengeHerpes simplex virus type 1 and bovine herpesvirus 1 latency.
P2860
Q22306291-3F84D322-4676-49B6-9218-66918CB09D5CQ24685440-9420F9D1-55BF-4DEB-A93C-47EBF2405F07Q26864175-0D0ED8CF-7EE6-470B-AAD0-67D18F894F39Q26999125-C8103324-B2A6-424E-85F6-1DC42CAC4D44Q27001272-49C22123-4F6F-49E3-BA14-6CC5F91222B0Q27310280-A7FC84E1-F8E9-4D93-A2A3-9BB4E6AA99A3Q27324479-41BEA6CE-994B-454F-AA94-5F8E25E17AF5Q28297488-19E24718-978F-4386-A4E2-71F36BB9172FQ30957753-5FE08ADC-7D0E-4FE5-982B-90ABE318D20BQ33248961-B338E948-85CE-4959-9A51-AE5C0697DE11Q33363111-7126063F-1AE6-49C4-ACAA-F3918F4EBE71Q33645342-840BF51D-EA65-4C34-906C-15D43138D1B5Q33653142-80D9E412-8AE0-4D6D-A215-4C5EE7099F64Q33654414-BA73E9FB-463B-4D95-8472-150791B71EA6Q33782992-B14177CD-7B4C-4131-B2D8-A662F78B46BAQ33785423-2BC340C9-E073-4E1B-9E5B-621C5C8B4504Q33785966-B3316A60-7F41-45FF-B497-3C58B0123F54Q33796650-44D2573C-49AC-4433-B33D-4CF67C28D73EQ33796821-5FFAB648-D2A4-4393-AAF0-E7D3F66596EFQ33816955-A0725C3A-54AC-427B-872C-2351678AFCA5Q33820864-0C5CF423-56CD-4D86-8F86-481649C5A19AQ33821358-934B9869-6CDA-4945-A84A-791AEFBEAB0DQ33834517-75FFB113-BEC9-46B3-BB95-BCAD0BA26C95Q33835246-4E528957-75B9-459D-B6BA-095BB75ACAC4Q33837275-93933870-2696-4342-BEAF-A1AC11711AB9Q33884066-CF24892D-B112-443D-AF97-B8C4C267717DQ33910593-E7827082-1DD5-4736-A6F0-2DA956F40CFAQ33963713-7CE953CE-39D9-41EB-B6DD-4CBF4C38259EQ34142760-31714D05-C9EF-40DB-9AE7-ED7F0B5D8102Q34340988-191D98AD-A559-4C8B-9EAA-FF10A8C27F62Q34344812-E14DA1A5-E572-45FC-BDF9-87611F916851Q34350019-B74CE92A-19F4-4682-9B9F-BECD6D2C1E88Q34350245-6C8E851B-951B-4194-A025-7A1BB4DCD3C3Q34356255-54E64937-9F19-47F0-B159-C1F4183CDAF5Q34545982-23AA25F9-8E8A-48AE-8A4C-AFB3B7FC6E66Q34648449-F961A4C9-E5F2-4A39-B31A-63D546B0FB75Q34777218-3AADFF5B-CAEB-4833-9E1D-5684D011FD6BQ34850941-A632E91E-F2FF-474A-8089-813A4A3931EAQ34992660-592A8676-BD10-4970-9F23-5FF6283F116FQ35044114-8D56C76F-72F4-491E-A72D-B7EE92F1D6B3
P2860
Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Anti-CD8 impairs clearance of ...... te of virally infected neurons
@ast
Anti-CD8 impairs clearance of ...... te of virally infected neurons
@en
type
label
Anti-CD8 impairs clearance of ...... te of virally infected neurons
@ast
Anti-CD8 impairs clearance of ...... te of virally infected neurons
@en
prefLabel
Anti-CD8 impairs clearance of ...... te of virally infected neurons
@ast
Anti-CD8 impairs clearance of ...... te of virally infected neurons
@en
P2860
P356
P1476
Anti-CD8 impairs clearance of ...... te of virally infected neurons
@en
P2093
Tscharke DC
P2860
P304
P356
10.1084/JEM.175.5.1337
P407
P577
1992-05-01T00:00:00Z